K-7174 dihydrochloride

CAS No. 191089-60-8

K-7174 dihydrochloride( —— )

Catalog No. M12994 CAS No. 191089-60-8

A selctive small molecule inhibitor of the transcription factor GATA-binding protein 2 (GATA2).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 412 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    K-7174 dihydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    A selctive small molecule inhibitor of the transcription factor GATA-binding protein 2 (GATA2).
  • Description
    A selctive small molecule inhibitor of the transcription factor GATA-binding protein 2 (GATA2); suppresses the expression of AR, including ARVs, in 22Rv1 cells, exertes potent anticancer activity against GATA2+/AR+ PC cell lines in vitro; induces transcriptional repression of class I histone deacetylases (HDAC1, -2, and -3) via caspase-8-dependent degradation of Sp1; significantly decreases HAMP expression, also upregulates CEBPB.(In Vitro):K-7174 dihydrochloride (10 μM; 1 h) inhibits the adhesion by VCAM-1 and its ligand.K-7174 dihydrochloride (1-30 μM; 1 h) dose-dependently suppresses the VCAM-1 expression with an IC50 value of 14 μM.K-7174 dihydrochloride (1-30 μM; 1 h) dose-dependently suppresses the induction of VCAM-1 mRNA by TNFα with an IC50 value of 9 μM.K-7174 dihydrochloride (10-20 μM; 24 h) dose-dependently rescues Epo production by Hep3B cells.K-7174 dihydrochloride (2.5-30 μM; 24 h) inhibits the binding activity of GATA.K-7174 dihydrochloride (0-25 μM; 72 h) inhibits MM cells growth and induces cell apoptosis.(In Vivo):K-7174 dihydrochloride (30 mg/kg; i.p. once daily for 9 days) reverses the decreasing of hemoglobin concentrations and reticulocyte counts by IL-1β or TNF-α.K-7174 dihydrochloride (75 mg/kg; i.p. once daily for 14 days) inhibits the tumor growth in vivo.K-7174 dihydrochloride (50 mg/kg; p.o. once daily for 14 days) inhibits the tumor growth in vivo and shows a better effect than intraperitoneal injection.
  • In Vitro
    K-7174 dihydrochloride (10 μM; 1 h) inhibits the adhesion by VCAM-1 and its ligand.K-7174 dihydrochloride (1-30 μM; 1 h) dose-dependently suppresses the VCAM-1 expression with an IC50 value of 14 μM.K-7174 dihydrochloride (1-30 μM; 1 h) dose-dependently suppresses the induction of VCAM-1 mRNA by TNFα with an IC50 value of 9 μM.K-7174 dihydrochloride (10-20 μM; 24 h) dose-dependently rescues Epo production by Hep3B cells.K-7174 dihydrochloride (2.5-30 μM; 24 h) inhibits the binding activity of GATA.K-7174 dihydrochloride (0-25 μM; 72 h) inhibits MM cells growth and induces cell apoptosis. Cell Viability Assay Cell Line:KMS12-BM, U266, and RPMI8226 cell lines Concentration:0-25 μM Incubation Time:72 h Result:Inhibited MM cells growth.Apoptosis Analysis Cell Line:KMS12-BM, U266, and RPMI8226 cell lines Concentration:10 μM Incubation Time:48 h Result:Significantly increased apoptosis of MM cells with the increasing percentage of annexin-V-positive cells.
  • In Vivo
    K-7174 dihydrochloride (30 mg/kg; i.p. once daily for 9 days) reverses the decreasing of hemoglobin concentrations and reticulocyte counts by IL-1β or TNF-α.K-7174 dihydrochloride (75 mg/kg; i.p. once daily for 14 days) inhibits the tumor growth in vivo.K-7174 dihydrochloride (50 mg/kg; p.o. once daily for 14 days) inhibits the tumor growth in vivo and shows a better effect than intraperitoneal injection. Animal Model:ICR mice with IL-β or TNF-α injection Dosage:30 mg/kg Administration:Intraperitoneal injection; 30 mg/kg once daily for 9 days Result:Increased erythropoietin (Epo) production, reticulocyte counts, and hemoglobin (Hb) concentrations.Animal Model:NOD/SCID mice with murine xenograft Dosage:75 mg/kg Administration:Intraperitoneal injection; once daily for 14 days Result:Significantly decreased tumor volume, but showed a significant body weight reduction after 10 days.Animal Model:NOD/SCID mice with murine xenograft Dosage:50 mg/kg Administration:Oral gavage; once daily for 14 daysResult:Showed an anti-myeloma activity. Porved oral administration is more effective than intraperitoneal injection.
  • Synonyms
    ——
  • Pathway
    Nuclear Receptor/Transcription Factor
  • Target
    GATA Binding Protein
  • Recptor
    GATA Binding Protein
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    191089-60-8
  • Formula Weight
    641.6659
  • Molecular Formula
    C33H50Cl2N2O6
  • Purity
    >98% (HPLC)
  • Solubility
    H2O: 15 mg/mL
  • SMILES
    COC1=CC(=CC(=C1OC)OC)C=CCCCN2CCCN(CC2)CCCC=CC3=CC(=C(C(=C3)OC)OC)OC.Cl.Cl
  • Chemical Name
    1H-1,4-Diazepine, hexahydro-1,4-bis[(4E)-5-(3,4,5-trimethoxyphenyl)-4-penten-1-yl]-, hydrochloride (1:2)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. He B, et al. Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18261-6. 2. Kikuchi J, et al. J Biol Chem. 2013 Aug 30;288(35):25593-602. 3. Fujiwara T, et al. PLoS One. 2013 Sep 27;8(9):e75568.
molnova catalog
related products
  • GATA4 activator 7

    A novel small molecule that activates GATA4/NKX2-5 transcriptional synergy with EC50 of 7 uM in cell reporter assay.

  • GATA4-IN-3

    A novel small molecule that inhibits GATA4/NKX2-5 transcriptional synergy with IC50 of 3 uM.

  • K-7174 dihydrochlori...

    A selctive small molecule inhibitor of the transcription factor GATA-binding protein 2 (GATA2).